mindact: adjuvant chemotherapy in breast cancer
Published 4 years ago • 1.3K plays • Length 8:10Download video MP4
Download video MP3
Similar videos
-
1:15
remaining questions regarding the use of adjuvant chemotherapy in breast cancer
-
1:19
optimizing adjuvant therapy: chemotherapy necessity in hr-positive breast cancer
-
2:46
adjuvant chemotherapy for breast cancer: who needs it?
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
4:13
genomic predictors for treatment selection in er breast cancer: tailorx, mindact, and rxponder
-
3:56
using mammaprint to select patients who may not need adjuvant chemotherapy – the results of mindact
-
1:01
exploring extended adjuvant chemotherapy for luminal cancers
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
2:20
escalation of adjuvant therapy in hr breast cancer
-
9:35
mindact long-term results: 70-gene signature mammaprint to guide adjuvant chemotherapy use in br...
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
3:35
the benefits of adjuvant cdk4/6 and parp inhibition in breast cancer
-
3:48
adjuvant therapy for breast cancer - mayo clinic
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
1:11:28
mammaprint blueprint, updates from mindact 8.7 year, & applications in neoadjuvant therapy
-
2:50
rxponder: sparing chemotherapy in node-positive early-stage breast cancer